Recombinant Haemophilus Influenzae ureG Protein (aa 1-225) (VAng-Lsx03951)
Haemophilus Influenzae (strain 86-028NP) Urease accessory protein UreG, recombinant protein.
Source
E. coli or Yeast or Baculovirus or Mammalian Cell.
Target
Haemophilus Influenzae
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
Tris-based buffer, 50% glycerol.
Purity
> 85% pure by SDS-PAGE.
Storage
Store at -20°C to -80°C.
Introduction
Haemophilus Influenzae, also known as Pfeiffer's bacillus or Bacillus influenzae, is a Gram-negative, coccobacillary, facultatively anaerobic pathogenic bacterium which is a member of the Pasteurellaceae family. H. influenzae is responsible for a wide range of localized and invasive infections. This species was the first free-living organism to have its entire genome sequenced. Six types of encapsulated Haemophilus Influenzae have been generally identified and are named as type a, b, c, d, e and f. Effective vaccines for Haemophilus Influenzae Type B have been available since the early 1990s, and is recommended for children under age 5 and asplenic patients.
Alternative Names
Pfeiffer's bacillus; Bacillus influenzae; H. influenzae
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.